Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials

Published:2015-09 Issue:13 Volume:51 Page:1704-1713
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Peeters M.,Kafatos G.,Taylor A.,Gastanaga V.M.,Oliner K.S.,Hechmati G.,Terwey J.-H.,van Krieken J.H.

Funder

Amgen Ltd

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J Clin Oncol,2008

2. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N Engl J Med,2004

3. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study;Douillard;J Clin Oncol,2010

4. Cetuximab for the treatment of colorectal cancer;Jonker;N Engl J Med,2007

5. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer;Peeters;J Clin Oncol,2010

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The RAS/BRAF genes status in patients with colorectal cancer (review);Koloproktologia;2024-09-21

2. Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study;Clinical and Translational Oncology;2024-04-20

3. Emerging role of liquid biopsy in rat sarcoma virus mutated metastatic colorectal cancer: A case report;World Journal of Gastrointestinal Oncology;2024-01-15

4. Intestinal transit-amplifying cells require METTL3 for growth factor signaling and cell survival;JCI Insight;2023-12-08

5. Identifying Genetic Mutation Status in Patients with Colorectal Cancer Liver Metastases Using Radiomics-Based Machine-Learning Models;Cancers;2023-11-29